US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Bioxytran, Inc.

0.0500

+0.00142.88%

Volume:77.12K

Turnover:3.85K

Market Cap:4.96M

PE:-2.09

High:0.0500

Open:0.0500

Low:0.0494

Close:0.0486

52wk High:0.2283

52wk Low:0.0342

Shares:99.10M

Float Shares:98.60M

Volume Ratio:1.01

T/O Rate:0.08%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0239

EPS(LYR):-0.0379

ROE:--

ROA:-687.83%

PB:-1.68

PE(LYR):-1.32

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Bioxytran, Inc.

Exchange:

OTCQB

Establishment Date:

2008

Employees:

- -

Office Location:

75 2nd Avenue,Ste 605,Needham,Massachusetts,United States

Website:

http://www.bioxytraninc.com

Zip Code:

02494

Phone:

Fax:

- -

Introduction:

Bioxytran, Inc., a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company's lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing. It is also developing ProLectin-Rx, a polysaccharide derived from pectin that binds to, and blocks the activity of galectin-1, a type of galectin for treatment of mild to moderate cases of Covid-19. The company was incorporated in 2008 and is headquartered in Newton, Massachusetts.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BIXT/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BIXT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIXT\",,,,,undefined,":{"symbol":"BIXT","market":"US","secType":"STK","nameCN":"Bioxytran, Inc.","latestPrice":0.05,"timestamp":1771439900976,"preClose":0.0486,"halted":0,"volume":77115,"delay":15,"changeRate":0.02880658436214003,"floatShares":98603900,"shares":99103900,"eps":-0.0239,"marketStatus":"Trading","change":0.0014,"latestTime":"02-18 13:38:20 EST Delay","open":0.05,"high":0.05,"low":0.049405,"amount":3852.056,"amplitude":0.012243,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.0239,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1771448400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.0486,"volumeRatio":1.013248},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIXT\",,,,,undefined,":{"symbol":"BIXT","floatShares":98603900,"roa":"-687.83%","roe":"--","lyrEps":-0.037945,"volumeRatio":1.013248,"shares":99103900,"dividePrice":0,"high":0.05,"amplitude":0.012243,"preClose":0.0486,"low":0.049405,"week52Low":0.0342,"pbRate":"-1.68","week52High":0.2283,"institutionHeld":0,"latestPrice":0.05,"eps":-0.0239,"divideRate":0,"volume":77115,"delay":15,"ttmEps":-0.0239,"open":0.05,"prevYearClose":0.0758,"prevWeekClose":0.0486,"prevMonthClose":0.0426,"prevQuarterClose":0.0758,"fiveDayClose":0.0471,"twentyDayClose":0.0596,"sixtyDayClose":0.088},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIXT\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIXT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIXT\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":582854619,"yearFounded":2008,"address":"75 2nd Avenue,Ste 605,Needham,Massachusetts,United States","zipCode":"02494","officePhone":"617 454 1199"},"stockCompanyDetail":{"websiteUrl":"http://www.bioxytraninc.com","stockEarnings":[{"period":"1week","weight":0.1998},{"period":"1month","weight":-0.1529},{"period":"3month","weight":0.1077},{"period":"6month","weight":0.44},{"period":"1year","weight":0.3846},{"period":"ytd","weight":0.4118}],"description":"Bioxytran, Inc., a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company's lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing. It is also developing ProLectin-Rx, a polysaccharide derived from pectin that binds to, and blocks the activity of galectin-1, a type of galectin for treatment of mild to moderate cases of Covid-19. The company was incorporated in 2008 and is headquartered in Newton, Massachusetts.","exchange":"OTCQB","name":"Bioxytran, Inc.","nameEN":"Bioxytran, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"BIXT\",market:\"US\",,,undefined,":null}}